Skip to main content

AusPAR: Rituximab

Australian Public Assessment Report
Device/Product Name
MabThera
Active ingredients
Rituximab
AusPAR Date
Published
Submission Number
PM-2013-04906-1-3
Submission Type
New dosing schedule
Decision
Approved

Help us improve the Therapeutic Goods Administration site